Alexander Stegh Receives ACGT Young Investigator Grant for Cutting-Edge Cell and Gene Therapy Research
Alexander Stegh, PhD, Assistant Professor in the Ken and Ruth Davee Department of Neurology at the Feinberg School of Medicine, has been awarded the 2012 "Young Investigator" Grant by the Alliance for Cancer Gene Therapy, Inc. (ACGT). The grant will support a study into a potential new treatment for brain cancer.
Stegh, who is also a member of the Lurie Cancer Center, seeks to better understand the metabolic vulnerabilities of glioblastoma (GBM). His research will help the Northwestern Brain Tumor Institute establish more effective methods of attacking and destroying GBM, a cancer that has been particularly resistant to treatment.
The Young Investigator Award is designed to help scientist who are conducting independent and innovative cell and gene therapy research for cancer in their own dedicated lab.
Read more about some of the cutting-edge research, including Dr. Stegh’s, that has allowed the word "cure" to become a part of the cancer conversation here.